| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8944921 | Clinical Microbiology and Infection | 2018 | 27 Pages |
Abstract
These findings support avoidance of fluoroquinolones for first-line UTI therapy in primary care, and suggest potential for interventions that interrupt household circulation of resistant Enterobacteriaceae.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
A.J. Stewardson, J. Vervoort, N. Adriaenssens, S. Coenen, M. Godycki-Cwirko, A. Kowalczyk, B.D. Huttner, C. Lammens, S. Malhotra-Kumar, H. Goossens, S. Harbarth,